Taiwan Shifting NHI Costs Through Rx Deregulation
This article was originally published in PharmAsia News
Executive Summary
Health authorities in Taiwan are planning to shift a group of prescription-only drugs to less restricted sale as part of a broader effort to foster "responsible self-medication" and save costs in the national insurance scheme.